Skip to main content
Tech.euFundingExplorerBeta

Vigil Neuroscience

Exited

Vigil Neuroscience is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain.

Watertown, United Stateswww.vigilneuro.com ↗
Healthtech
← All companies
Total raised
€0
€0
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
Aug 2025
Value
—
Acquiror
Sanofi (France)

Related news

Similar companies

same sector or country